12 Aug
|
Novartis
|
India
This job is with Novartis, an inclusive employer and a member of myGwork – the largest global platform for the LGBTQ business community. Please do not contact the recruiter directly. Summary To support in delivering analytics and strategic decision support for early-stage pipeline assets and therapeutic area access teams. The role will contribute to the development of forward-looking access strategies by translating epidemiology, payer dynamics, HTA requirements, pricing benchmarks, competitive intelligence, and real-world evidence analogs into actionable insights. Support the development of forward-looking access strategies for early pipeline assets and relevant analytics. The position will support early asset access strategy development, scenario modeling, pricing and reimbursement assumptions, and executive-ready deliverables across the IV&A; value chain. About the Role Key responsibilities:
Develop optimal knowledge and experience in V&A; / HTA / PMA Develop and maintain the qualitative and/or quantitative deliverables as per the stakeholder requirements in accordance with the agreed standard process and timelines, independently for assigned projects Liaise with stakeholders on project schedule/planning of deliverables Ensure that the recent associates/junior colleagues deliver quality deliverables by providing guidance and performing QC/review Support early access analytics and strategy for pipeline (pre-TDP) assets, including market, access, pricing, and reimbursement hypotheses translating early asset data and market uncertainty into clear, actionable insights, decision-support materials, and access strategy frameworks Conduct payer and HTA landscape assessments, analog reviews, and benchmark analyses to identify access risks and opportunities across key markets. Support pricing, reimbursement, and access considerations to inform BD&L; activities and target product profiles Help develop assumptions for forecasting, including epidemiology, patient flows, competiti
📌 Manager - TA Access Early Assets-1 (India)
🏢 Novartis
📍 India